HLMA.L vs. NOV.DE
HLMA.L (Halma plc) and NOV.DE (Novo Nordisk A/S) are both stocks. HLMA.L operates in Conglomerates (Industrials), while NOV.DE operates in Biotechnology (Healthcare). Over the past 10 years, HLMA.L returned 18.37%/yr vs 10.69%/yr for NOV.DE. At a 0.25 correlation, their price movements are largely independent.
Performance
HLMA.L vs. NOV.DE - Performance Comparison
Loading charts...
Different Trading Currencies
HLMA.L is traded in GBp, while NOV.DE is traded in EUR. To make them comparable, the NOV.DE values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, HLMA.L achieves a 33.47% return, which is significantly higher than NOV.DE's -11.31% return. Over the past 10 years, HLMA.L has outperformed NOV.DE with an annualized return of 18.37%, while NOV.DE has yielded a comparatively lower 10.69% annualized return.
HLMA.L
- 1D
- 1.24%
- 1M
- 3.80%
- YTD
- 33.47%
- 6M
- 29.66%
- 1Y
- 59.70%
- 3Y*
- 26.08%
- 5Y*
- 12.90%
- 10Y*
- 18.37%
NOV.DE
- 1D
- 4.34%
- 1M
- -1.51%
- YTD
- -11.31%
- 6M
- -3.22%
- 1Y
- -37.57%
- 3Y*
- -17.47%
- 5Y*
- 5.24%
- 10Y*
- 10.69%
HLMA.L vs. NOV.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HLMA.L Halma plc | 33.47% | 32.52% | 18.70% | 16.78% | -37.74% | 31.48% | 16.58% | 56.35% | 9.47% | 42.10% |
NOV.DE Novo Nordisk A/S | -11.31% | -43.10% | -13.69% | 46.60% | 37.72% | 61.40% | 19.73% | 28.35% | 21.15% | 40.67% |
Correlation
The correlation between HLMA.L and NOV.DE is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jul 5, 2007 | 0.25 |
The correlation between HLMA.L and NOV.DE shifts across timeframes, from 0.08 (1 year) to 0.25 (10 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HLMA.L vs. NOV.DE — Risk / Return Rank
HLMA.L
NOV.DE
HLMA.L vs. NOV.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Halma plc (HLMA.L) and Novo Nordisk A/S (NOV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HLMA.L | NOV.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.07 | ||
| Sortino ratioReturn per unit of downside risk | +4.05 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 0.90 | +0.52 |
| Calmar ratioReturn relative to maximum drawdown | 4.39 | -0.67 | +5.06 |
| Martin ratioReturn relative to average drawdown | 17.18 | -1.01 | +18.19 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HLMA.L | NOV.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.40 | -0.67 | +3.07 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.50 | 0.14 | +0.36 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.74 | 0.32 | +0.43 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.71 | 0.55 | +0.16 |
Drawdowns
HLMA.L vs. NOV.DE - Drawdown Comparison
The maximum HLMA.L drawdown since its inception was -42.86%, smaller than the maximum NOV.DE drawdown of -75.95%. Use the drawdown chart below to compare losses from any high point for HLMA.L and NOV.DE.
Loading charts...
Drawdown Indicators
| HLMA.L | NOV.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.86% | -75.95% | +33.09% |
Max Drawdown (1Y)Largest decline over 1 year | -13.53% | -53.54% | +40.01% |
Max Drawdown (3Y)Largest decline over 3 years | -25.75% | -75.95% | +50.20% |
Max Drawdown (5Y)Largest decline over 5 years | -42.86% | -75.95% | +33.09% |
Max Drawdown (10Y)Largest decline over 10 years | -42.86% | -75.95% | +33.09% |
Current DrawdownCurrent decline from peak | -3.20% | -69.85% | +66.65% |
Average DrawdownAverage peak-to-trough decline | -10.17% | -11.41% | +1.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.46% | 35.69% | -32.23% |
Volatility
HLMA.L vs. NOV.DE - Volatility Comparison
Halma plc (HLMA.L) and Novo Nordisk A/S (NOV.DE) have volatilities of 8.81% and 8.67%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HLMA.L | NOV.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.81% | 8.67% | +0.14% |
Volatility (6M)Calculated over the trailing 6-month period | 19.91% | 39.32% | -19.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.85% | 53.41% | -28.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.91% | 37.96% | -12.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.72% | 33.68% | -8.96% |
Dividends
HLMA.L vs. NOV.DE - Dividend Comparison
HLMA.L's dividend yield for the trailing twelve months is around 0.50%, less than NOV.DE's 4.11% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLMA.L Halma plc | 0.50% | 0.67% | 0.83% | 0.91% | 0.98% | 0.57% | 0.69% | 0.76% | 1.11% | 1.12% | 0.00% | 0.00% |
NOV.DE Novo Nordisk A/S | 4.11% | 3.54% | 1.58% | 1.01% | 1.17% | 1.27% | 1.98% | 2.08% | 27.19% | 2.27% | 3.67% | 1.25% |
Financials
HLMA.L vs. NOV.DE - Financials Comparison
This section allows you to compare key financial metrics between Halma plc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
HLMA.L and NOV.DE have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for HLMA.L and NOV.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer